Nicolas Vabret, PhD
img_Nicolas Vabret
ASSISTANT PROFESSOR | Immunology & Immunotherapy
ASSISTANT PROFESSOR | Oncological Sciences
Research Topics
Aging, Cancer, Coronavirus, HIV/AIDS, Immunology, Infectious Disease, Inflammation, Interferon, RNA, Retrovirus, Vaccine Development, Viruses and Virology
Multi-Disciplinary Training Area
Cancer Biology [CAB], Genetics and Genomic Sciences [GGS], Immunology [IMM], Microbiology [MIC]
Immunology
Vabret lab website
  • Cancer Immunotherapy
  • Transposable Elements
  • Aging
  • Vaccines

PhD, Institut Pasteur

Publications

Selected Publications

Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms. Siyu Sun, Eunae You, Jungeui Hong, David Hoyos, Isabella Del Priore, Kaloyan M. Tsanov, Om Mattagajasingh, Andrea Di Gioacchino, Sajid A. Marhon, Jonathan Chacon-Barahona, Hao Li, Hua Jiang, Samira Hozeifi, Omar Rosas-Bringas, Katherine H. Xu, Yuhui Song, Evan R. Lang, Alexandra S. Rojas, Linda T. Nieman, Bidish K. Patel, Rajmohan Murali, Pharto Chanda, Ali Karacay, Nicolas Vabret, Daniel D. De Carvalho, Daniel Zenklusen, John LaCava, Scott W. Lowe, David T. Ting, Christine A. Iacobuzio-Donahue, Alexander Solovyov, Benjamin D. Greenbaum. Immunity

Interferon response and epigenetic modulation by SMARCA4 mutations drive ovarian tumor immunogenicity. Melica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu, Ana Leda F. Longhini, Andrea Gazzo, Siyu Sun, Richard P. Koche, Rui Qu, Laura Rosenberg, Pierre Jacques Hamard, Yonina Bykov, Hunter Green, Laxmi Gusain, Katherine B. Chiappinelli, Melih Arda Ozsoy, M. Herman Chui, Thais Basili, Rui Gardner, Sven Walderich, Elisa DeStanchina, Benjamin Greenbaum, Mithat Gönen, Nicolas Vabret, Britta Weigelt, Dmitriy Zamarin. Science advances

Hematopoietic aging promotes cancer by fueling IL-1a–driven emergency myelopoiesis. Matthew D. Park, Jessica Le Berichel, Pauline Hamon, C. Matthias Wilk, Meriem Belabed, Nader Yatim, Alexis Saffon, Jesse Boumelha, Chiara Falcomatà, Alexander Tepper, Samarth Hegde, Raphaël Mattiuz, Brian Y. Soong, Nelson M. LaMarche, Frederika Rentzeperis, Leanna Troncoso, Laszlo Halasz, Clotilde Hennequin, Theodore Chin, Earnest P. Chen, Amanda M. Reid, Matthew Su, Ashley Reid Cahn, Laura L. Koekkoek, Nicholas Venturini, Shira Wood-Isenberg, Darwin D’souza, Rachel Chen, Travis Dawson, Kai Nie, Zhihong Chen, Seunghee Kim-Schulze, Maria Casanova-Acebes, Filip K. Swirski, Julian Downward, Nicolas Vabret, Brian D. Brown, Thomas U. Marron, Miriam Merad. Journal of Bio-X Research

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Vabret has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.